Biotechnological applications of mobile group II introns and their reverse transcriptases: Gene targeting, RNA-seq, and non-coding RNA analysis

Mobile DNA

Volumn 5, Issue 1, 2014, Pages

  Enyeart, Peter J ^a   Mohr, Georg ^a   Ellington, Andrew D ^a   Lambowitz, Alan M ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Genome engineering; Metabolic engineering; Next generation RNA sequencing; Ribozyme; Synthetic biology; Systems biology; Targetron

Indexed keywords

COMPLEMENTARY DNA; DNA; MAGNESIUM; RECOMBINASE; RIBOZYME; RNA; RNA DIRECTED DNA POLYMERASE; UNTRANSLATED RNA;

ALGORITHM; BACTERIUM; BASE PAIRING; BIOTECHNOLOGY; EUKARYOTE; GENE DELETION; GENE TARGETING; GENETIC ENGINEERING; GENOME; INTRON; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROPOSON; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; THERMOPHILE;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 84892424438     PISSN: None     EISSN: 17598753     Source Type: Journal    
DOI: 10.1186/1759-8753-5-2     Document Type: Review

References (191)

1. Group II introns: ribozymes that splice RNA and invade DNA. Pyle AM, Lambowitz AM, The RNA World, Third Edition Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press, Gesteland RF, Cech T, Atkins JF, 2006 469 505
2. Bacterial group II introns: not just splicing. Toro N, Jiménez-Zurdo JI, García-Rodríguez FM, FEMS Microbiol Rev 2007 31 342 358 10.1111/j.1574-6976.2007.00068.x 17374133 (Pubitemid 46525312)
3. Group II introns: mobile ribozymes that invade DNA. Lambowitz AM, Zimmerly S, Cold Spring Harb Perspect Biol 2011 3 003616 20463000
4. Mobile group II introns. Lambowitz AM, Zimmerly S, Annu Rev Genet 2004 38 1 35 10.1146/annurev.genet.38.072902.091600 15568970 (Pubitemid 40013722)
5. Group II introns designed to insert into therapeutically relevant DNA target sites in human cells. Guo H, Karberg M, Long M, Jones JP 3rd, Sullenger B, Lambowitz AM, Science 2000 289 452 457 10.1126/science.289.5478.452 10903206 (Pubitemid 30490457)
6. Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Karberg M, Guo H, Zhong J, Coon R, Perutka J, Lambowitz AM, Nat Biotechnol 2001 19 1162 1167 10.1038/nbt1201-1162 11731786 (Pubitemid 33115703)
7. Use of computer-designed group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes. Perutka J, Wang W, Goerlitz D, Lambowitz AM, J Mol Biol 2004 336 421 439 10.1016/j.jmb.2003.12.009 14757055 (Pubitemid 38147637)
8. Retrohoming of a bacterial group II intron: mobility via complete reverse splicing, independent of homologous DNA recombination. Cousineau B, Smith D, Lawrence-Cavanagh S, Mueller JE, Yang J, Mills D, Manias D, Dunny G, Lambowitz AM, Belfort M, Cell 1998 94 451 462 10.1016/S0092-8674(00)81586-X 9727488 (Pubitemid 28391861)
9. Localization, mobility and fidelity of retrotransposed group II introns in rRNA genes. Conlan LH, Stanger MJ, Ichiyanagi K, Belfort M, Nucleic Acids Res 2005 33 5262 5270 10.1093/nar/gki819 16170154 (Pubitemid 41508683)
10. Thermostable group II intron reverse transcriptase fusion proteins and their use in cDNA synthesis and next-generation RNA sequencing. Mohr S, Ghanem E, Smith W, Sheeter D, Qin Y, King O, Polioudakis D, Iyer VR, Hunicke-Smith S, Swamy S, Kuersten S, Lambowitz AM, RNA 2013 19 958 970 10.1261/rna.039743.113 23697550
11. A group II intron-type open reading frame from the thermophile Bacillus (Geobacillus) stearothermophilus encodes a heat-stable reverse transcriptase. Vellore J, Moretz SE, Lampson BC, Appl Environ Microbiol 2004 70 7140 7147 10.1128/AEM.70.12.7140-7147.2004 15574910 (Pubitemid 39643776)
12. Reverse transcriptases: intron-encoded proteins found in thermophilic bacteria. Ng B, Nayak S, Gibbs MD, Lee J, Bergquist PL, Gene 2007 393 137 144 10.1016/j.gene.2007.02.003 17363195 (Pubitemid 46551535)
13. Enzyme engineering through evolution: thermostable recombinant group II intron reverse transcriptases provide new tools for RNA research and biotechnology. Collins K, Nilsen TW, RNA 2013 19 1017 1018 10.1261/rna.040451. 113 23793892
14. Introns and the origin of nucleus-cytosol compartmentalization. Martin W, Koonin EV, Nature 2006 440 41 45 10.1038/nature04531 16511485 (Pubitemid 43336261)
15. A structural analysis of the group II intron active site and implications for the spliceosome. Keating KS, Toor N, Perlman PS, Pyle AM, RNA 2010 16 1 9 10.1261/rna.1791310 19948765
16. Database for bacterial group II introns. Candales MA, Duong A, Hood KS, Li T, Neufeld RA, Sun R, McNeil BA, Wu L, Jarding AM, Zimmerly S, Nucleic Acids Res 2012 40 187 D190 10.1093/nar/gkr1043 22080509
17. Structure and activities of group II introns. Michel F, Ferat JL, Annu Rev Biochem 1995 64 435 461 10.1146/annurev.bi.64.070195.002251 7574489
18. The architectural organization and mechanistic function of group II intron structural elements. Qin PZ, Pyle AM, Curr Opin Struct Biol 1998 8 301 308 10.1016/S0959-440X(98)80062-6 9666325 (Pubitemid 28321356)
19. Crystal structure of a self-spliced group II intron. Toor N, Keating KS, Taylor SD, Pyle AM, Science 2008 320 77 82 10.1126/science.1153803 18388288 (Pubitemid 351490756)
20. Tertiary architecture of the Oceanobacillus iheyensis group II intron. Toor N, Keating KS, Fedorova O, Rajashankar K, Wang J, Pyle AM, RNA 2010 16 57 69 10.1261/rna.1844010 19952115
21. Now on display: a gallery of group II intron structures at different stages of catalysis. Marcia M, Somarowthu S, Pyle AM, Mob DNA 2013 4 14 10.1186/1759-8753-4-14 23634971
22. Mobility of the Sinorhizobium meliloti group II intron RmInt1 occurs by reverse splicing into DNA, but requires an unknown reverse transcriptase priming mechanism. Muñoz-Adelantado E, San Filippo J, Martínez-Abarca F, García-Rodríguez FM, Lambowitz AM, Toro N, J Mol Biol 2003 327 931 943 10.1016/S0022-2836(03)00208-0 12662921 (Pubitemid 36363703)
23. Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase. Blocker FJ, Mohr G, Conlan LH, Qi L, Belfort M, Lambowitz AM, RNA 2005 11 14 28 10.1261/rna.7181105 15574519 (Pubitemid 40041569)
24. Group II intron mobility occurs by target DNA-primed reverse transcription. Zimmerly S, Guo H, Perlman PS, Lambowitz AM, Cell 1995 82 545 554 10.1016/0092-8674(95)90027-6 7664334
25. A group II intron RNA is a catalytic component of a DNA endonuclease involved in intron mobility. Zimmerly S, Guo H, Eskes R, Yang J, Perlman PS, Lambowitz AM, Cell 1995 83 529 538 10.1016/0092-8674(95)90092-6 7585955
26. Efficient integration of an intron RNA into double-stranded DNA by reverse splicing. Yang J, Zimmerly S, Perlman PS, Lambowitz AM, Nature 1996 381 332 335 10.1038/381332a0 8692273 (Pubitemid 26156090)
27. Group II intron mobility using nascent strands at DNA replication forks to prime reverse transcription. Zhong J, Lambowitz AM, EMBO J 2003 22 4555 4565 10.1093/emboj/cdg433 12941706 (Pubitemid 37087208)
28. The RmInt1 group II intron has two different retrohoming pathways for mobility using predominantly the nascent lagging strand at DNA replication forks for priming. Martínez-Abarca F, Barrientos-Durán A, Fernández-López M, Toro N, Nucleic Acids Res 2004 32 2880 2888 10.1093/nar/gkh616 15155857 (Pubitemid 38898626)
29. Comprehensive phylogenetic analysis of bacterial group II intron-encoded ORFs lacking the DNA endonuclease domain reveals new varieties. Toro N, Martínez-Abarca F, PLoS One 2013 8 55102 10.1371/journal.pone.0055102 23355907
30. Genetic and biochemical assays reveal a key role for replication restart proteins in group II intron retrohoming. Yao J, Truong DM, Lambowitz AM, PLoS Genet 2013 9 1003469 10.1371/journal.pgen.1003469 23637634
31. Recruitment of host functions suggests a repair pathway for late steps in group II intron retrohoming. Smith D, Zhong J, Matsuura M, Lambowitz AM, Belfort M, Genes Dev 2005 19 2477 2487 10.1101/gad.1345105 16230535 (Pubitemid 41483695)
32. Group II intron splicing in vivo by first-step hydrolysis. Podar M, Chu VT, Pyle AM, Perlman PS, Nature 1998 391 915 918 10.1038/36142 9495347 (Pubitemid 28157672)
33. Lariat formation and a hydrolytic pathway in plant chloroplast group II intron splicing. Vogel J, Börner T, EMBO J 2002 21 3794 3803 10.1093/emboj/cdf359 12110591 (Pubitemid 34787052)
34. Group II intron-based gene targeting reactions in eukaryotes. Mastroianni M, Watanabe K, White TB, Zhuang F, Vernon J, Matsuura M, Wallingford J, Lambowitz AM, PLoS One 2008 3 3121 10.1371/journal.pone.0003121 18769669
35. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Gaj T, Gersbach CA, Barbas CF 3rd, Trends Biotechnol 2013 31 397 405 10.1016/j.tibtech.2013.04.004 23664777
36. Linear group II intron RNAs can retrohome in eukaryotes and may use nonhomologous end-joining for cDNA ligation. Zhuang F, Mastroianni M, White TB, Lambowitz AM, Proc Natl Acad Sci USA 2009 106 18189 18194 10.1073/pnas. 0910277106 19833873
37. The retrohoming of linear group II intron RNAs in Drosophila melanogaster occurs by both DNA ligase 4-dependent and -independent mechanisms. White TB, Lambowitz AM, PLoS Genet 2012 8 1002534 10.1371/journal.pgen.1002534 22359518
38. Group II intron endonucleases use both RNA and protein subunits for recognition of specific sequences in double-stranded DNA. Guo H, Zimmerly S, Perlman PS, Lambowitz AM, EMBO J 1997 16 6835 6848 10.1093/emboj/16.22.6835 9362497 (Pubitemid 27503495)
39. Interaction of a group II intron ribonucleoprotein endonuclease with its DNA target site investigated by DNA footprinting and modification interference. Singh NN, Lambowitz AM, J Mol Biol 2001 309 361 386 10.1006/jmbi.2001.4658 11371159 (Pubitemid 32553494)
40. Atomic force microscopy reveals DNA bending during group II intron ribonucleoprotein particle integration into double-stranded DNA. Noah JW, Park S, Whitt JT, Perutka J, Frey W, Lambowitz AM, Biochemistry 2006 45 12424 12435 10.1021/bi060612h 17029398 (Pubitemid 44583685)
41. A three-dimensional perspective on exon binding by a group II self-splicing intron. Costa M, Michel F, Westhof E, EMBO J 2000 19 5007 5018 10.1093/emboj/19.18.5007 10990464
42. EcI5, a group IIB intron with high retrohoming frequency: DNA target site recognition and use in gene targeting. Zhuang F, Karberg M, Perutka J, Lambowitz AM, RNA 2009 15 432 449 10.1261/rna.1378909 19155322
43. DNA target site requirements for homing in vivo of a bacterial group II intron encoding a protein lacking the DNA endonuclease domain. Jiménez-Zurdo JI, García-Rodríguez FM, Barrientos- Durán A, Toro N, J Mol Biol 2003 326 413 423 10.1016/S0022-2836(02)01380- 3 12559910 (Pubitemid 36279336)
44. Self-splicing of a group IIC intron: 5' exon recognition and alternative 5' splicing events implicate the stem-loop motif of a transcriptional terminator. Toor N, Robart AR, Christianson J, Zimmerly S, Nucleic Acids Res 2006 34 6461 6471 10.1093/nar/gkl820 17130159 (Pubitemid 46017943)
45. Insertion of group II intron retroelements after intrinsic transcriptional terminators. Robart AR, Seo W, Zimmerly S, Proc Natl Acad Sci USA 2007 104 6620 6625 10.1073/pnas.0700561104 17420455 (Pubitemid 47175550)
46. Group IIC intron mobility into attC sites involves a bulged DNA stem-loop motif. Léon G, Roy PH, RNA 2009 15 1543 1553 10.1261/rna.1649309 19509303
47. Retrotransposition strategies of the Lactococcus lactis Ll.LtrB group II intron are dictated by host identity and cellular environment. Coros CJ, Landthaler M, Piazza CL, Beauregard A, Esposito D, Perutka J, Lambowitz AM, Belfort M, Mol Microbiol 2005 56 509 524 10.1111/j.1365-2958.2005.04554.x 15813740 (Pubitemid 40516787)
48. Sequence specificity of a group II intron ribozyme: multiple mechanisms for promoting unusually high discrimination against mismatched targets. Xiang Q, Qin PZ, Michels WJ, Freeland K, Pyle AM, Biochemistry 1998 37 3839 3849 10.1021/bi972661n 9521704 (Pubitemid 28162940)
49. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E, Science 2012 337 816 821 10.1126/science.1225829 22745249
50. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Cho SW, Kim S, Kim JM, Kim JS, Nat Biotechnol 2013 31 230 232 10.1038/nbt.2507 23360966
51. Multiplex genome engineering using CRISPR/Cas systems. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F, Science 2013 339 819 823 10.1126/science.1231143 23287718
52. Efficient genome editing in zebrafish using a CRISPR-Cas system. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK, Nat Biotechnol 2013 31 227 229 10.1038/nbt.2501 23360964
53. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA, Nat Biotechnol 2013 31 233 239 10.1038/nbt.2508 23360965
54. RNA-guided human genome engineering via Cas9. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM, Science 2013 339 823 826 10.1126/science.1232033 23287722
55. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Hou Z, Zhang Y, Propson NE, Howden SE, Chu LF, Sontheimer EJ, Thomson JA, Proc Natl Acad Sci USA 2013 110 15644 15649 10.1073/pnas.1313587110 23940360
56. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD, Nat Biotechnol 2013 31 822 826 10.1038/nbt.2623 23792628
57. Use of RmInt1, a group IIB intron lacking the intron-encoded protein endonuclease domain, in gene targeting. García-Rodríguez FM, Barrientos-Durán A, Díaz-Prado V, Fernández-López M, Toro N, Appl Environ Microbiol 2011 77 854 861 10.1128/AEM.02319-10 21115708
58. Rules for DNA target-site recognition by a lactococcal group II intron enable retargeting of the intron to specific DNA sequences. Mohr G, Smith D, Belfort M, Lambowitz AM, Genes Dev 2000 14 559 573 10716944 (Pubitemid 30159775)
59. Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker. Zhong J, Karberg M, Lambowitz AM, Nucleic Acids Res 2003 31 1656 1664 10.1093/nar/gkg248 12626707 (Pubitemid 36336567)
60. Generalized bacterial genome editing using mobile group II introns and Cre-lox. Enyeart PJ, Chirieleison SM, Dao MN, Perutka J, Quandt EM, Yao J, Whitt JT, Keatinge-Clay AT, Lambowitz AM, Ellington AD, Mol Syst Biol 2013 9 685 24002656
61. Genetic manipulation of Lactococcus lactis by using targeted group II introns: generation of stable insertions without selection. Frazier CL, San Filippo J, Lambowitz AM, Mills DA, Appl Environ Microbiol 2003 69 1121 1128 10.1128/AEM.69.2.1121-1128.2003 12571038 (Pubitemid 36204843)
62. Use of targetrons to disrupt essential and nonessential genes in Staphylococcus aureus reveals temperature sensitivity of Ll.LtrB group II intron splicing. Yao J, Zhong J, Fang Y, Geisinger E, Novick RP, Lambowitz AM, RNA 2006 12 1271 1281 10.1261/rna.68706 16741231 (Pubitemid 43990552)
63. The ClosTron: a universal gene knock-out system for the genus Clostridium. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP, J Microbiol Methods 2007 70 452 464 10.1016/j.mimet.2007.05.021 17658189 (Pubitemid 47302149)
64. Gene targeting in Gram-negative bacteria by use of a mobile group II intron ("targetron") expressed from a broad-host-range vector. Yao J, Lambowitz AM, Appl Environ Microbiol 2007 73 2735 2743 10.1128/AEM.02829-06 17322321 (Pubitemid 46668768)
65. Retrotransposition of the Ll.LtrB group II intron proceeds predominantly via reverse splicing into DNA targets. Ichiyanagi K, Beauregard A, Lawrence S, Smith D, Cousineau B, Belfort M, Mol Microbiol 2002 46 1259 1272 12453213 (Pubitemid 36961261)
66. Gene targeting using randomly inserted group II introns (targetrons) recovered from an Escherichia coli gene disruption library. Yao J, Zhong J, Lambowitz AM, Nucleic Acids Res 2005 33 3351 3362 10.1093/nar/gki649 15947133 (Pubitemid 41194479)
67. An ipdC gene knock-out of Azospirillum brasilense strain SM and its implications on indole-3-acetic acid biosynthesis and plant growth promotion. Malhotra M, Srivastava S, Antonie Van Leeuwenhoek 2008 93 425 433 10.1007/s10482-007-9207-x 17952626 (Pubitemid 351436844)
68. Two independent replicons can support replication of the anthrax toxin-encoding plasmid pXO1 of Bacillus anthracis. Akhtar P, Khan SA, Plasmid 2012 67 111 117 10.1016/j.plasmid.2011.12.012 22239982
69. Construction of an alpha toxin gene knockout mutant of Clostridium perfringens type A by use of a mobile group II intron. Chen Y, McClane BA, Fisher DJ, Rood JI, Gupta P, Appl Environ Microbiol 2005 71 7542 7547 10.1128/AEM.71.11.7542-7547.2005 16269799 (Pubitemid 43194251)
70. Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection. Cheng C, Nair AD, Indukuri VV, Gong S, Felsheim RF, Jaworski D, Munderloh UG, Ganta RR, PLoS Pathog 2013 9 1003171 10.1371/journal.ppat.1003171 23459099
71. Targeted inactivation of Francisella tularensis genes by group II introns. Rodriguez SA, Yu JJ, Davis G, Arulanandam BP, Klose KE, Appl Environ Microbiol 2008 74 2619 2626 10.1128/AEM.02905-07 18310413 (Pubitemid 351632592)
72. The posttranslocation chaperone PrsA2 contributes to multiple facets of Listeria monocytogenes pathogenesis. Alonzo F 3rd, Port GC, Cao M, Freitag NE, Infect Immun 2009 77 2612 2623 10.1128/IAI.00280-09 19451247
73. Construction of a gene knockout system for application in Paenibacillus alvei CCM 2051 T, exemplified by the S-layer glycan biosynthesis initiation enzyme WsfP. Zarschler K, Janesch B, Zayni S, Schäffer C, Messner P, Appl Environ Microbiol 2009 75 3077 3085 10.1128/AEM.00087-09 19304819
74. Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors. Steen JA, Steen JA, Harrison P, Seemann T, Wilkie I, Harper M, Adler B, Boyce JD, PLoS Pathog 2010 6 1000750 10.1371/journal.ppat.1000750 20140235
75. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. Pearson MM, Mobley HL, J Med Microbiol 2007 56 1277 1283 10.1099/jmm.0.47314-0 17893161 (Pubitemid 350105592)
76. Development of a gene knockout system for Ralstonia eutropha H16 based on the broad-host-range vector expressing a mobile group II intron. Park JM, Jang YS, Kim TY, Lee SY, FEMS Microbiol Lett 2010 309 193 200 20608980
77. Characterization of the achromobactin iron acquisition operon in Sodalis glossinidius. Smith CL, Weiss BL, Aksoy S, Runyen-Janecky LJ, Appl Environ Microbiol 2013 79 2872 2881 10.1128/AEM.03959-12 23435882
78. Cloning and molecular analysis of a mannitol operon of phosphoenolpyruvate-dependent phosphotransferase (PTS) type from Vibrio cholerae O395. Kumar S, Smith KP, Floyd JL, Varela MF, Arch Microbiol 2011 193 201 208 10.1007/s00203-010-0663-8 21184218
79. Expression of signal transduction system encoding genes of Yersinia pseudotuberculosis IP32953 at 28°C and 3°C. Palonen E, Lindstrom M, Karttunen R, Somervuo P, Korkeala H, PLoS One 2011 6 25063 10.1371/journal.pone. 0025063 21949852
80. The ClosTron: mutagenesis in Clostridium refined and streamlined. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC, Minton NP, J Microbiol Methods 2010 80 49 55 10.1016/j.mimet.2009.10.018 19891996
81. A type III-like restriction endonuclease functions as a major barrier to horizontal gene transfer in clinical Staphylococcus aureus strains. Corvaglia AR, Francois P, Hernandez D, Perron K, Linder P, Schrenzel J, Proc Natl Acad Sci USA 2010 107 11954 11958 10.1073/pnas.1000489107 20547849
82. Mobility of yeast mitochondrial group II introns: engineering a new site specificity and retrohoming via full reverse splicing. Eskes R, Yang J, Lambowitz AM, Perlman PS, Cell 1997 88 865 874 10.1016/S0092-8674(00)81932-7 9118229 (Pubitemid 27164274)
83. Multiple homing pathways used by yeast mitochondrial group II introns. Eskes R, Liu L, Ma H, Chao MY, Dickson L, Lambowitz AM, Perlman PS, Mol Cell Biol 2000 20 8432 8446 10.1128/MCB.20.22.8432-8446.2000 11046140
84. Retroids in archaea: phylogeny and lateral origins. Rest JS, Mindell DP, Mol Biol Evol 2003 20 1134 1142 10.1093/molbev/msg135 12777534 (Pubitemid 36792829)
85. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Sayeed S, Uzal FA, Fisher DJ, Saputo J, Vidal JE, Chen Y, Gupta P, Rood JI, McClane BA, Mol Microbiol 2008 67 15 30 18078439 (Pubitemid 350231133)
86. Identification of migR, a regulatory element of the Francisella tularensis live vaccine strain iglABCD virulence operon required for normal replication and trafficking in macrophages. Buchan BW, McCaffrey RL, Lindemann SR, Allen LA, Jones BD, Infect Immun 2009 77 2517 2529 10.1128/IAI.00229-09 19349423
87. TcsL is an essential virulence factor in Clostridium sordellii ATCC 9714. Carter GP, Awad MM, Hao Y, Thelen T, Bergin IL, Howarth PM, Seemann T, Rood JI, Aronoff DM, Lyras D, Infect Immun 2011 79 1025 1032 10.1128/IAI.00968-10 21199912
88. Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. Francis MB, Allen CA, Shrestha R, Sorg JA, PLoS Pathog 2013 9 1003356 10.1371/journal.ppat.1003356 23675301
89. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant Staphylococcus aureus. Zoraghi R, See RH, Gong H, Lian T, Swayze R, Finlay BB, Brunham RC, McMaster WR, Reiner NE, Biochemistry 2010 49 7733 7747 10.1021/bi100780t 20707314
90. Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activities. Zoraghi R, Worrall L, See RH, Strangman W, Popplewell WL, Gong H, Samaai T, Swayze RD, Kaur S, Vuckovic M, Finlay BB, Brunham RC, McMaster WR, Davies-Coleman MT, Strynadka NC, Andersen RJ, Reiner NE, J Biol Chem 2011 286 44716 44725 10.1074/jbc.M111.289033 22030393
91. Multicopy integration of heterologous genes, using the lactococcal group II intron targeted to bacterial insertion sequences. Rawsthorne H, Turner KN, Mills DA, Appl Environ Microbiol 2006 72 6088 6093 10.1128/AEM.02992-05 16957233 (Pubitemid 44414640)
92. Targeted gene disruption by use of a group II intron (targetron) vector in Clostridium acetobutylicum. Shao L, Hu S, Yang Y, Gu Y, Chen J, Yang Y, Jiang W, Yang S, Cell Res 2007 17 963 965 10.1038/cr.2007.91 17971808 (Pubitemid 350126868)
93. Disruption of the acetoacetate decarboxylase gene in solvent-producing Clostridium acetobutylicum increases the butanol ratio. Jiang Y, Xu C, Dong F, Yang Y, Jiang W, Yang S, Metab Eng 2009 11 284 291 10.1016/j.ymben.2009.06.002 19560551
94. Targeted gene inactivation in Clostridium phytofermentans shows that cellulose degradation requires the family 9 hydrolase Cphy3367. Tolonen AC, Chilaka AC, Church GM, Mol Microbiol 2009 74 1300 1313 10.1111/j.1365-2958.2009. 06890.x 19775243
95. Genetic manipulation of butyrate formation pathways in Clostridium butyricum. Cai G, Jin B, Saint C, Monis P, J Biotechnol 2011 155 269 274 10.1016/j.jbiotec.2011.07.004 21787814
96. Switching Clostridium acetobutylicum to an ethanol producer by disruption of the butyrate/butanol fermentative pathway. Lehmann D, Lütke-Eversloh T, Metab Eng 2011 13 464 473 10.1016/j.ymben.2011.04.006 21549853
97. Targeted mutagenesis of the Clostridium acetobutylicum acetone-butanol-ethanol fermentation pathway. Cooksley CM, Zhang Y, Wang H, Redl S, Winzer K, Minton NP, Metab Eng 2012 14 630 641 10.1016/j.ymben.2012.09.001 22982601
98. Enhanced butanol production obtained by reinforcing the direct butanol-forming route in Clostridium acetobutylicum. Jang YS, Lee JY, Lee J, Park JH, Im JA, Eom MH, Lee SH, Song H, Cho JH, Seung Do Y, Lee SY, mBio 2012 3 12
99. Identification and characterization of two functionally unknown genes involved in butanol tolerance of Clostridium acetobutylicum. Jia K, Zhang Y, Li Y, PLoS One 2012 7 38815 10.1371/journal.pone.0038815 22768047
100. Disruption of the acetate kinase (ack) gene of Clostridium acetobutylicum results in delayed acetate production. Kuit W, Minton NP, López- Contreras AM, Eggink G, Appl Microbiol Biotechnol 2012 94 729 741 10.1007/s00253-011-3848-4 22249720
101. Modifying the product pattern of Clostridium acetobutylicum: physiological effects of disrupting the acetate and acetone formation pathways. Lehmann D, Hönicke D, Ehrenreich A, Schmidt M, Weuster-Botz D, Bahl H, Lütke-Eversloh T, Appl Microbiol Biotechnol 2012 94 743 754 10.1007/s00253-011-3852-8 22246530
102. Combined inactivation of the Clostridium cellulolyticum lactate and malate dehydrogenase genes substantially increases ethanol yield from cellulose and switchgrass fermentations. Li Y, Tschaplinski TJ, Engle NL, Hamilton CY, Rodriguez M Jr, Liao JC, Schadt CW, Guss AM, Yang Y, Graham DE, Biotechnol Biofuels 2012 5 2 10.1186/1754-6834-5-2 22214220
103. An agr quorum sensing system that regulates granulose formation and sporulation in Clostridium acetobutylicum. Steiner E, Scott J, Minton NP, Winzer K, Appl Environ Microbiol 2012 78 1113 1122 10.1128/AEM.06376-11 22179241
104. The redox-sensing protein Rex, a transcriptional regulator of solventogenesis in Clostridium acetobutylicum. Wietzke M, Bahl H, Appl Microbiol Biotechnol 2012 96 749 761 10.1007/s00253-012-4112-2 22576944
105. A genetic and metabolic approach to redirection of biochemical pathways of Clostridium butyricum for enhancing hydrogen production. Cai G, Jin B, Monis P, Saint C, Biotechnol Bioeng 2013 110 338 342 10.1002/bit.24596 22753004
106. A two-component system (XydS/R) controls the expression of genes encoding CBM6-containing proteins in response to straw in Clostridium cellulolyticum. Celik H, Blouzard JC, Voigt B, Becher D, Trotter V, Fierobe HP, Tardif C, Pagès S, de Philip P, PLoS One 2013 8 56063 10.1371/journal.pone.0056063 23418511
107. Regulation of cel genes of C. cellulolyticum: identification of GlyR2, a transcriptional regulator regulating cel5D gene expression. Fendri I, Abdou L, Trotter V, Dedieu L, Maamar H, Minton NP, Tardif C, PLoS One 2013 8 44708 10.1371/journal.pone.0044708 23349658
108. Are cellulosome scaffolding protein CipC and CBM3-containing protein HycP, involved in adherence of Clostridium cellulolyticum to cellulose? Ferdinand PH, Borne R, Trotter V, Pagès S, Tardif C, Fierobe HP, Perret S, PLoS One 2013 8 69360 10.1371/journal.pone.0069360 23935995
109. Metabolic engineering of Clostridium acetobutylicum for enhanced production of butyric acid. Jang YS, Woo HM, Im JA, Kim IH, Lee SY, Appl Microbiol Biotechnol 2013 97 9355 9363 10.1007/s00253-013-5161-x 24013291
110. Development of a gene knockout system using mobile group II introns (targetron) and genetic disruption of acid production pathways in Clostridium beijerinckii. Wang Y, Li X, Milne CB, Janssen H, Lin W, Phan G, Hu H, Jin Y-S, Price ND, Blaschek HP, Appl Environ Microbiol 2013 79 5853 5863 10.1128/AEM.00971-13 23872562
111. A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein. Emerson JE, Reynolds CB, Fagan RP, Shaw HA, Goulding D, Fairweather NF, Mol Microbiol 2009 74 541 556 10.1111/j.1365-2958.2009.06812.x 19656296
112. Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile. Kirby JM, Ahern H, Roberts AK, Kumar V, Freeman Z, Acharya KR, Shone CC, J Biol Chem 2009 284 34666 34673 10.1074/jbc.M109.051177 19808679
113. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, Lewis RJ, Wilcox MH, Stephenson K, J Bacteriol 2009 191 7296 7305 10.1128/JB.00882-09 19783633
114. SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate. Burns DA, Heap JT, Minton NP, J Bacteriol 2010 192 657 664 10.1128/JB.01209-09 19933358
115. CcpA-mediated repression of Clostridium difficile toxin gene expression. Antunes A, Martin-Verstraete I, Dupuy B, Mol Microbiol 2011 79 882 899 10.1111/j.1365-2958.2010.07495.x 21299645
116. Role of fibronectin-binding protein A in Clostridium difficile intestinal colonization. Barketi-Klai A, Hoys S, Lambert-Bordes S, Collignon A, Kansau I, J Med Microbiol 2011 60 1155 1161 10.1099/jmm.0.029553-0 21349990
117. The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. Dawson LF, Donahue EH, Cartman ST, Barton RH, Bundy J, McNerney R, Minton NP, Wren BW, BMC Microbiol 2011 11 86 10.1186/1471-2180-11-86 21527013
118. Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters. Dingle TC, Mulvey GL, Armstrong GD, Infect Immun 2011 79 4061 4067 10.1128/IAI.05305-11 21788384
119. PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function sigma factors in Clostridium difficile. Ho TD, Ellermeier CD, Infect Immun 2011 79 3229 3238 10.1128/IAI.00019-11 21628514
120. Both, toxin A and toxin B, are important in Clostridium difficile infection. Kuehne SA, Cartman ST, Minton NP, Gut Microbes 2011 2 252 255 10.4161/gmic.2.4.16109 21804353
121. The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. McBride SM, Sonenshein AL, Microbiology 2011 157 1457 1465 10.1099/mic.0.045997-0 21330441
122. Roles of cysteine proteases Cwp84 and Cwp13 in biogenesis of the cell wall of Clostridium difficile. de la Riva L, Willing SE, Tate EW, Fairweather NF, J Bacteriol 2011 193 3276 3285 10.1128/JB.00248-11 21531808
123. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I, J Bacteriol 2011 193 3186 3196 10.1128/JB.00272-11 21572003
124. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm. Bakker D, Smits WK, Kuijper EJ, Corver J, PLoS One 2012 7 43247 10.1371/journal.pone.0043247 22912837
125. Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW, PLoS One 2012 7 50527 10.1371/journal.pone.0050527 23236376
126. The Clostridium difficile spo0A gene is a persistence and transmission factor. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, Wren BW, Fairweather NF, Dougan G, Lawley TD, Infect Immun 2012 80 2704 2711 10.1128/IAI.00147-12 22615253
127. Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. Govind R, Dupuy B, PLoS Pathog 2012 8 1002727 10.1371/journal.ppat.1002727 22685398
128. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Olling A, Seehase S, Minton NP, Tatge H, Schröter S, Kohlscheen S, Pich A, Just I, Gerhard R, Microb Pathog 2012 52 92 100 10.1016/j.micpath.2011.10.009 22107906
129. Structural and functional analysis of the CspB protease required for Clostridium spore germination. Adams CM, Eckenroth BE, Putnam EE, Doublié S, Shen A, PLoS Pathog 2013 9 1003165 10.1371/journal.ppat.1003165 23408892
130. Proline-dependent regulation of Clostridium difficile Stickland metabolism. Bouillaut L, Self WT, Sonenshein AL, J Bacteriol 2013 195 844 854 10.1128/JB.01492-12 23222730
131. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. apa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M, J Bacteriol 2013 195 545 555 10.1128/JB.01980-12 23175653
132. The agr locus regulates virulence and colonization genes in Clostridium difficile 027. Martin MJ, Clare S, Goulding D, Faulds-Pain A, Barquist L, Browne HP, Pettit L, Dougan G, Lawley TD, Wren BW, J Bacteriol 2013 195 3672 3681 10.1128/JB.00473-13 23772065
133. SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins. Putnam EE, Nock AM, Lawley TD, Shen A, J Bacteriol 2013 195 1214 1225 10.1128/JB.02181-12 23292781
134. Functional characterization of Clostridium difficile spore coat proteins. Permpoonpattana P, Phetcharaburanin J, Mikelsone A, Dembek M, Tan S, Brisson MC, La Ragione R, Brisson AR, Fairweather N, Hong HA, Cutting SM, J Bacteriol 2013 195 1492 1503 10.1128/JB.02104-12 23335421
135. The functional vanG§ssub§Cd§esub§ cluster of Clostridium difficile does not confer vancomycin resistance. Ammam F, Meziane-cherif D, Mengin-Lecreulx D, Blanot D, Patin D, Boneca IG, Courvalin P, Lambert T, Candela T, Mol Microbiol 2013 89 612 625 10.1111/mmi.12299 23782343
136. The role of flagella in Clostridium difficile pathogenesis: comparison between a non-epidemic and an epidemic strain. Baban ST, Kuehne SA, Barketi-Klai A, Cartman ST, Kelly ML, Hardie KR, Kansau I, Collignon A, Minton NP, PLoS One 2013 8 73026 10.1371/journal.pone.0073026 24086268
137. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, Sonnenburg JL, Nature 2013 502 96 99 10.1038/nature12503 23995682
138. CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen. Tulli L, Marchi S, Petracca R, Shaw HA, Fairweather NF, Scarselli M, Soriani M, Leuzzi R, Cell Microbiol 2013 15 1674 1687 23517059
139. Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile. Saujet L, Pereira FC, Serrano M, Soutourina O, Monot M, Shelyakin PV, Gelfand MS, Dupuy B, Henriques AO, Martin-Verstraete I, PLoS Genet 2013 9 1003756 10.1371/journal.pgen.1003756 24098137
140. The second messenger cyclic di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD. McKee RW, Mangalea MR, Purcell EB, Borchardt EK, Tamayo R, J Bacteriol 2013 195 5174 5185 10.1128/JB.00501-13 24039264
141. The spore differentiation pathway in the enteric pathogen Clostridium difficile. Pereira FC, Saujet L, Tome AR, Serrano M, Monot M, Couture-Tosi E, Martin-Verstraete I, Dupuy B, Henriques AO, PLoS Genet 2013 9 1003782 10.1371/journal.pgen.1003782 24098139
142. Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Janoir C, Denève C, Bouttier S, Barbut F, Hoys S, Caleechum L, Chapetón-Montes D, Pereira FC, Henriques AO, Collignon A, Monot M, Dupuy B, Infect Immun 2013 81 3757 3769 10.1128/IAI.00515-13 23897605
143. Global analysis of the sporulation pathway of Clostridium difficile. Fimlaid KA, Bond JP, Schutz KC, Putnam EE, Leung JM, Lawley TD, Shen A, PLoS Genet 2013 9 1003660 10.1371/journal.pgen.1003660 23950727
144. Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies. Bradshaw M, Marshall KM, Heap JT, Tepp WH, Minton NP, Johnson EA, Appl Environ Microbiol 2010 76 387 393 10.1128/AEM.02005-09 19933346
145. Regulation of neurotoxin production and sporulation by a putative agrBD signaling system in proteolytic Clostridium botulinum. Cooksley CM, Davis IJ, Winzer K, Chan WC, Peck MW, Minton NP, Appl Environ Microbiol 2010 76 4448 4460 10.1128/AEM.03038-09 20453132
146. Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum. Marshall KM, Bradshaw M, Johnson EA, PLoS One 2010 5 11087 10.1371/journal.pone.0011087 20552020
147. Important role of class I heat shock genes hrcA and dnaK in the heat shock response and the response to pH and NaCl stress of group I Clostridium botulinum strain ATCC 3502. Selby K, Lindström M, Somervuo P, Heap JT, Minton NP, Korkeala H, Appl Environ Microbiol 2011 77 2823 2830 10.1128/AEM.02633-10 21378058
148. cspB encodes a major cold shock protein in Clostridium botulinum ATCC 3502. Söderholm H, Lindström M, Somervuo P, Heap J, Minton N, Linden J, Korkeala H, Int J Food Microbiol 2011 146 23 30 10.1016/j.ijfoodmicro.2011. 01.033 21367479
149. Involvement of Clostridium botulinum ATCC 3502 sigma factor K in early-stage sporulation. Kirk DG, Dahlsten E, Zhang Z, Korkeala H, Lindström M, Appl Environ Microbiol 2012 78 4590 4596 10.1128/AEM.00304-12 22544236
150. Involvement of two-component system CBO0366/CBO0365 in the cold shock response and growth of group I (proteolytic) Clostridium botulinum ATCC 3502 at low temperatures. Lindström M, Dahlsten E, Söderholm H, Selby K, Somervuo P, Heap JT, Minton NP, Korkeala H, Appl Environ Microbiol 2012 78 5466 5470 10.1128/AEM.00555-12 22660717
151. Alternative sigma factor SigK has a role in stress tolerance of group I Clostridium botulinum strain ATCC 3502. Dahlsten E, Kirk D, Lindström M, Korkeala H, Appl Environ Microbiol 2013 79 3867 3869 10.1128/AEM.04036-12 23563953
152. Two-component signal transduction system CBO0787/CBO0786 represses transcription from botulinum neurotoxin promoters in Clostridium botulinum ATCC 3502. Zhang Z, Korkeala H, Dahlsten E, Sahala E, Heap JT, Minton NP, Lindström M, PLoS Pathog 2013 9 1003252 10.1371/journal.ppat.1003252 23555260
153. The two-component system CBO2306/CBO2307 is important for cold adaptation of Clostridium botulinum ATCC 3502. Derman Y, Isokallio M, Lindström M, Korkeala H, Int J Food Microbiol 2013 167 87 91 10.1016/j.ijfoodmicro.2013.06. 004 23810493
154. Clostridium perfringens spore germination: characterization of germinants and their receptors. Paredes-Sabja D, Torres JA, Setlow P, Sarker MR, J Bacteriol 2008 190 1190 1201 10.1128/JB.01748-07 18083820 (Pubitemid 351214999)
155. Contact with enterocyte-like Caco-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates. Vidal JE, Ohtani K, Shimizu T, McClane BA, Cell Microbiol 2009 11 1306 1328 10.1111/j.1462-5822. 2009.01332.x 19438515
156. The VirSR two-component signal transduction system regulates NetB toxin production in Clostridium perfringens. Cheung JK, Keyburn AL, Carter GP, Lanckriet AL, Van Immerseel F, Moore RJ, Rood JI, Infect Immun 2010 78 3064 3072 10.1128/IAI.00123-10 20457789
157. Evaluating the involvement of alternative sigma factors SigF and SigG in Clostridium perfringens sporulation and enterotoxin synthesis. Li J, McClane BA, Infect Immun 2010 78 4286 4293 10.1128/IAI.00528-10 20643850
158. Epsilon-toxin production by Clostridium perfringens type D strain CN3718 is dependent upon the agr operon but not the VirS/VirR two-component regulatory system. Chen J, Rood JI, McClane BA, mBio 2011 2 00275 11 22167225
159. Glycoside hydrolase family 89 -N-acetylglucosaminidase from Clostridium perfringens specifically acts on GlcNAc1,4Galβ1R at the non-reducing terminus of O-glycans in gastric mucin. Fujita M, Tsuchida A, Hirata A, Kobayashi N, Goto K, Osumi K, Hirose Y, Nakayama J, Yamanoi T, Ashida H, Mizuno M, J Biol Chem 2011 286 6479 6489 10.1074/jbc.M110.206722 21177247
160. The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603. Li J, Chen J, Vidal JE, McClane BA, Infect Immun 2011 79 2451 2459 10.1128/IAI.00169-11 21464088
161. Sialidases affect the host cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens type D strain CN3718. Li J, Sayeed S, Robertson S, Chen J, McClane BA, PLoS Pathog 2011 7 1002429 10.1371/journal. ppat.1002429 22174687
162. Role of the Agr-like quorum-sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795. Chen J, McClane BA, Infect Immun 2012 80 3008 3017 10.1128/IAI.00438-12 22689820
163. The Clostridium perfringens germinant receptor protein GerKC is located in the spore inner membrane and is crucial for spore germination. Banawas S, Paredes-Sabja D, Korza G, Li Y, Hao B, Setlow P, Sarker MR, J Bacteriol 2013 195 5084 5091 10.1128/JB.00901-13 24013629
164. CodY is a global regulator of virulence-associated properties for Clostridium perfringens type D strain CN3718. Li J, Ma M, Sarker MR, McClane BA, mBio 2013 4 00770 13 24105766
165. Identification and characterization of Clostridium sordellii toxin gene regulator. Sirigi Reddy AR, Girinathan BP, Zapotocny R, Govind R, J Bacteriol 2013 195 4246 4254 10.1128/JB.00711-13 23873908
166. Engineering Clostridium strain to accept unmethylated DNA. Dong H, Zhang Y, Dai Z, Li Y, PLoS One 2010 5 9038 10.1371/journal.pone.0009038 20161730
167. Targeted gene engineering in Clostridium cellulolyticum H10 without methylation. Cui GZ, Hong W, Zhang J, Li WL, Feng Y, Liu YJ, Cui Q, J Microbiol Methods 2012 89 201 208 10.1016/j.mimet.2012.02.015 22450138
168. Rapid targeted gene disruption in Bacillus anthracis. Saldanha RJ, Pemberton A, Shiflett P, Perutka J, Whitt JT, Ellington A, Lambowitz AM, Kramer R, Taylor D, Lamkin TJ, BMC Biotechnol 2013 13 72 10.1186/1472-6750-13-72 24047152
169. Disruption of a toxin gene by introduction of a foreign gene into the chromosome of Clostridium perfringens using targetron-induced mutagenesis. Chen Y, Caruso L, McClane B, Fisher D, Gupta P, Plasmid 2007 58 182 189 10.1016/j.plasmid.2007.04.002 17553563 (Pubitemid 47241246)
170. Restriction for gene insertion within the Lactococcus lactis Ll.LtrB group II intron. Plante I, Cousineau B, RNA 2006 12 1980 1992 10.1261/rna.193306 16973892 (Pubitemid 44771757)
171. Group II intron-anchored gene deletion in Clostridium. Jia K, Zhu Y, Zhang Y, Li Y, PLoS One 2011 6 16693 10.1371/journal.pone.0016693 21304965
172. Genome engineering. Carr PA, Church GM, Nat Biotechnol 2009 27 1151 1162 10.1038/nbt.1590 20010598
173. The automation of science. King RD, Rowland J, Oliver SG, Young M, Aubrey W, Byrne E, Liakata M, Markham M, Pir P, Soldatova LN, Sparks A, Whelan KE, Clare A, Science 2009 324 85 89 10.1126/science.1165620 19342587
174. Programming cells by multiplex genome engineering and accelerated evolution. Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR, Church GM, Nature 2009 460 894 898 10.1038/nature08187 19633652
175. Developments in industrially important thermostable enzymes: a review. Haki GD, Rakshit SK, Bioresource Technol 2003 89 17 34 10.1016/S0960-8524(03) 00033-6 (Pubitemid 36379207)
176. Potential and utilization of thermophiles and thermostable enzymes in biorefining. Turner P, Mamo G, Karlsson EN, Microb Cell Fact 2007 6 9 10.1186/1475-2859-6-9 17359551 (Pubitemid 46566595)
177. Genetic tool development underpins recent advances in thermophilic whole-cell biocatalysts. Taylor MP, van Zyl L, Tuffin IM, Leak DJ, Cowan DA, Microb Biotechnol 2011 4 438 448 10.1111/j.1751-7915.2010.00246.x 21310009
178. A targetron system for gene targeting in thermophiles and its application in Clostridium thermocellum. Mohr G, Hong W, Zhang J, Cui GZ, Yang Y, Cui Q, Liu YJ, Lambowitz AM, PLoS One 2013 8 69032 10.1371/journal.pone.0069032 23874856
179. Fermentation of cellulosic substrates in batch and continuous culture by Clostridium thermocellum. Lynd LR, Grethlein HE, Wolkin RH, Appl Environ Microbiol 1989 55 3131 3139 16348075 (Pubitemid 20002124)
180. Cre recombinase: the universal reagent for genome tailoring. Nagy A, Genesis 2000 26 99 109 10.1002/(SICI)1526-968X(200002)26:2<99::AID- GENE1>3.0.CO;2-B 10686599 (Pubitemid 30158089)
181. Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity? Claverys JP, Prudhomme M, Mortier-Barrière I, Martin B, Mol Microbiol 2000 35 251 259 10.1046/j.1365-2958.2000.01718.x 10652087 (Pubitemid 30055223)
182. Acinetobacter sp. ADP1: an ideal model organism for genetic analysis and genome engineering. Metzgar D, Bacher JM, Pezo V, Reader J, Döring V, Schimmel P, Marlière P, de Crécy-Lagard V, Nucleic Acids Res 2004 32 5780 5790 10.1093/nar/gkh881 15514111 (Pubitemid 39619161)
183. High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides. Ellis HM, Yu D, DiTizio T, Court DL, Proc Natl Acad Sci USA 2001 98 6742 6746 10.1073/pnas.121164898 11381128 (Pubitemid 32538287)
184. Enhanced levels of λ Red-mediated recombinants in mismatch repair mutants. Costantino N, Court DL, Proc Natl Acad Sci USA 2003 100 15748 15753 10.1073/pnas.2434959100 14673109 (Pubitemid 38021061)
185. Magnesium and the growth of Escherichia coli. Lusk JE, Williams RJ, Kennedy EP, J Biol Chem 1968 243 2618 2624 4968384
186. Gonadotropin stimulates oocyte translation by increasing magnesium activity through intracellular potassium-magnesium exchange. Horowitz SB, Tluczek LJ, Proc Natl Acad Sci USA 1989 86 9652 9656 10.1073/pnas.86.24.9652 2513575 (Pubitemid 20030691)
187. Concentration, compartmentation and metabolic function of intracellular free Mg§ssup§2+§esup§ Günther T, Magnes Res 2006 19 225 236 17402290 (Pubitemid 46361324)
188. Retargeting mobile group II introns to repair mutant genes. Jones JP 3rd, Kierlin MN, Coon RG, Perutka J, Lambowitz AM, Sullenger BA, Mol Ther 2005 11 687 694 10.1016/j.ymthe.2005.01.014 15851007 (Pubitemid 40567973)
189. White TB, Group II intron retrohoming and gene targeting reactions in Drosophila melanogaster University of Texas: Cell and Molecular Biology PhD thesis. 2011
190. Enhanced group II intron retrohoming in magnesium-deficient Escherichia coli via selection of mutations in the ribozyme core. Truong DM, Sidote DJ, Russell R, Lambowitz AM, Proc Natl Acad Sci USA 2013 110 3800 E3809 10.1073/pnas.1315742110 24043808
191. HIV-1 reverse transcription. Hu WS, Hughes SH, Cold Spring Harb Perspect Med 2012 2 006882 23028129